Immunovant, Inc. (IMVT) Tops Q3 EPS by 11c
Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.